"FOXO4-DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53-serine 15 phosphorylation"
Certain factors may increase the likelihood of experiencing bloating on GLP-1 therapy, including: Pre-existing gastrointestinal conditions such as irritable bowel syndrome (IBS), functional dyspepsia, or small intestinal bacterial overgrowth (SIBO) Rapid dose escalation without adequate titration periods Dietary factors , particularly high intake of fermentable carbohydrates (FODMAPs), fatty foods, or carbonated beverages Concurrent medications that affect gastrointestinal motility Patients should be aware that GLP-1 receptor agonists have been associated with more serious gastrointestinal adverse effects, including pancreatitis (inflammation of the pancreas) and gallbladder disease
Saying "I have noticed my desire has changed since starting this medication, and I want to work through it with you" is infinitely more productive than silently withdrawing from intimacy and leaving a partner to wonder why
Its published telehealth red flags include any company that does not require screening and a prescription by a licensed clinician before providing medicine, or that has no licensed clinician available afterwards
JACC CardioOncol
Regular sessions can help maintain long-term radiance
.webp)
